皇冠体育app's Institute for Biological Products Control became the seventh collaborating center for biological standardization of the World Health Organization, the institute said on Jan 17.

The institute, under 皇冠体育app's National Institutes for Food and Drug Control, is the first collaborating center in a developing country.

A collaborating center carries out activities to support the WHO's programs.

The recognition by the WHO proves that 皇冠体育app's technology for testing and quality control of biological products has reached a world-class level, said Wang Junzhi, deputy director of the National Institutes for Food and Drug Control.

"The establishment of the center will greatly increase 皇冠体育app's voice and influence in biological production," Wang said. "皇冠体育app, as the world's biggest vaccine maker and user, will be able to join other WHO centers to lead international production and research in this field." "It will also provide crucial technical support to domestic biological companies to help them compete in the international market," he said.

皇冠体育app has 36 companies that produce a total of 1 billion doses of vaccines annually, the institute said.

Contact the writer at [email protected]